Green tea has been consumed for approximately five thousand years. It is one of the most studied plant compounds in modern scientific literature, with thousands of peer-reviewed studies investigating its mechanisms. The active compound — EGCG, epigallocatechin gallate — represents 30 to 40 percent of green tea's dry weight. And it does things that took decades of research to fully articulate: it blocks viral attachment to respiratory epithelial cells, activates the body's master antioxidant system, modulates inflammatory gene expression, and works synergistically with L-theanine to produce calm focused alertness without the cortisol spike of caffeine alone. Five thousand years was not a mistake.

EGCG and the Respiratory System

EGCG's antiviral activity against respiratory viruses operates through a specific mechanism: inhibition of the hemagglutinin protein that viruses use to attach to respiratory epithelial cells. By blocking this attachment step before infection is established, EGCG acts as a first-line viral defense at the airway surface. Simultaneously, it reduces airway inflammation by inhibiting NF-kB and the downstream production of IL-6 and TNF-alpha in bronchial tissue. And it protects respiratory epithelial cells from the oxidative damage caused by air pollutants and pathogen-induced oxidative stress through both direct free radical scavenging and Nrf2 pathway activation.

L-theanine is an amino acid found almost exclusively in the tea plant. It promotes alpha wave induction in the brain — the electrical pattern associated with relaxed alertness. It modulates caffeine's sympathetic nervous system activation, reducing the cortisol spike and anxiety that caffeine alone produces. The caffeine-theanine combination in green tea produces sustained alertness and focus without jitteriness — a cognitive state multiple controlled trials have confirmed is superior for attention and task performance compared to either compound alone. This is why green tea feels different from coffee. The chemistry is different.

Cardiovascular Evidence That Holds Up

Epidemiological studies in Japan consistently show associations between regular green tea intake and reduced cardiovascular disease mortality. Controlled intervention studies have demonstrated reductions in LDL oxidation, improvements in endothelial function, reductions in C-reactive protein, and modest blood pressure lowering. Meta-analyses confirm consistent LDL and total cholesterol reductions. The convergence of epidemiological, clinical, and mechanistic evidence for green tea cardiovascular benefits is among the strongest in botanical medicine. Five thousand years of cultivation. Consistent modern research confirmation. The power has always been there.

Educational Purposes Only: This article is for informational use only and does not constitute medical advice. These statements have not been evaluated by the FDA. APLGO products are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement.